The ingredient clinically researched for its therapeutic potential in easing anxiety and stress in adults
Cambridge Commodities has extended its range of ingredients with Gencor’s Calmaluma.
The product is an extract derived from Caralluma fimbriata, a succulent plant. The ingredient has been designated not novel in food supplements and is affirmed safe by six toxicity studies, the company says.
It’s created using a patented process which extracts the key constituents of the plant. Cressida Cable, Head of Product Development, said: “This process has allowed Gencor to develop an effective, safe, and easy-to-use ingredient. Not only this, Calmaluma has been clinically researched for both its safety and functionality, providing additional assurance to manufacturers and end consumer.”
The product is available as a 90% water-soluble free flowing powder. Additionally, it offers heat, acidic and alkaline stability, making it suitable for use in capsules, tablets, and powder blends. With rigorous research, Gencor established CFE's mechanisms in-vitro and in-vivo and its influence on receptors involved in mood regulation.
Caralluma fimbriata is an edible plant from India where it grows abundantly and has been used in Indian culture for thousands of years. Typically, it blooms in late summer with brown, purple, tan, yellow or red blossoms.